Author

E. Caleiras

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Benguria· 1 shared A. Cerezo· 1 shared A. Dopazo· 1 shared A. Efeyan· 1 shared A. Hernandez-Barranco· 1 shared A. Hernandez-Lain· 1 shared A. Martin· 1 shared A. Martinez-Ramirez· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Benguria

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NGFR regulates germinal center B-cell activation and negative selection

A. Hernandez-Barranco, M. S. Mazariegos, V. Santos, E. Caleiras, L. Nogues, F. Mourcin, S. Leonard, C. Oblet, S. Genebrier, D. Rossille, A. Benguria, E. Vazquez, A. Dopazo, A. Efeyan, A. Ortega-Molina, , H. Peinado

This study shows that NGFR regulates germinal center B-cell activation and negative selection by maintaining GC structure and function, affecting antibody production and immune tolerance.

bioRxiv · Jul 14, 2023 · PreprintImmunology

Targeting the mitochondrial RNA methyltransferase TRMT61B reveals new therapeutic opportunities in aneuploid cancer cells

A. Martin, B. Vilaplana-Marti, R. I. Macias, A. Martinez-Ramirez, A. Cerezo, P. Cabezas-Sainz, M. G. Asensio, C. Epifano, S. Amarilla, D. Gomez-Dominguez, I. Hernandez, E. Caleiras, J. Camps, R. Barderas, L. Sanchez, , I. Perez de Castro

This study identifies TRMT61B as a therapeutic target in aneuploid cancer cells by showing its role in mitochondrial function and tumor progression.

bioRxiv · Apr 25, 2021Cancer Biology

A drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent local relapse and treat established brain metastasis

L. Zhu, N. Yebra, D. Retana, L. Miarka, E. Hernandez-Encinas, C. Blanco-Aparicio, S. Martinez, R. Soffietti, L. Bertero, P. Cassoni, T. Weiss, J. Munoz, J. M. Sepulveda, A. Perez-Nunez, A. Hernandez-Lain, , M. Valiente

The paper introduces a drug-screening platform using organotypic cultures to identify effective treatments for brain metastasis, finding a potent HSP90 inhibitor that works against mouse and human metastases.

bioRxiv · Oct 16, 2020 · PreprintCancer Biology